Works (1)
Updated: July 5th, 2023 15:37
2017 journal article
Is CCNU (lomustine) valuable for treatment of cutaneous epitheliotropic lymphoma in dogs? A critically appraised topic
BMC VETERINARY RESEARCH, 13(1).
Contributors: n & T. Olivry n
author keywords: Canine; Chemotherapy; Dog; Epitheliotropic; Lomustine; Lymphosarcoma; Mycosis fungoides; Neoplasia
MeSH headings : Animals; Antineoplastic Agents, Alkylating / therapeutic use; Dog Diseases / drug therapy; Dogs; Lomustine / therapeutic use; Lymphoma, T-Cell, Cutaneous / drug therapy; Lymphoma, T-Cell, Cutaneous / veterinary; Remission Induction; Treatment Outcome
TL;DR:
The search for, and review and analysis of, the best evidence available suggests that CCNU and pegylated liposomal doxorubicin appear to yield the highest rate of complete remission in approximately one-third of dogs with CTCL.
(via Semantic Scholar)
bmcvetres.biomedcentral.com (publisher PDF)
UN Sustainable Development Goal Categories
3. Good Health and Well-being
(Web of Science; OpenAlex)
Sources: Web Of Science, ORCID, NC State University Libraries
Added: August 6, 2018
Citation Index includes data from a number of different sources. If you have questions about the sources of data in the Citation Index or need a set of data which is free to re-distribute, please contact us.
Certain data included herein are derived from the Web of Science© and InCites© (2024) of Clarivate Analytics. All rights reserved. You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
